Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Design Therapeutics, Inc. (DSGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2023 |
SC 13G
| CITADEL ADVISORS LLC reports a 5.1% stake in Design Therapeutics, Inc. |
| 02/08/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
SC 13G
| BlackRock Inc. reports a 6.3% stake in DESIGN THERAPEUTICS INC |
| 12/22/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/13/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 5.3% stake in DESIGN THERAPEUTICS, INC. |
| 02/09/2022 |
SC 13G
| Ansari Aseem Z. reports a 13.8% stake in Design Therapeutics, Inc., a Delaware corporation |
| 02/09/2022 |
SC 13G
| Light Irrevocable Trust #1 dated April 22, 2019 reports a 6.9% stake in Design Therapeutics, Inc., a Delaware corporation |
| 02/09/2022 |
SC 13G
| Star Irrevocable Trust #1 dated April 22, 2019 reports a 6.9% stake in Design Therapeutics, Inc., a Delaware corporation |
| 04/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|